Biophytis S.A.. (1/20/21). "Press Release: Biophytis Announces Public Filing of a Registration Statement for Proposed Initial Public Offering in the United States". Paris & Cambridge, MA. |
2021-01-20 |
ConserV Bioscience Ltd.. (1/19/21). "Press Release: ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine". London & Livermore, CA. |
2021-01-19 |
Thermo Fisher Scientific Inc.. (1/19/21). "Press Release: Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech". Waltham, MA. |
2021-01-19 |
Forbion Capital Partners. (1/19/21). "Press Release: Forbion Invests USD 2.3M in Seed Financing of CoviCept Therapeutics, Inc.". Naarden. |
2021-01-19 |
Slate Bio, Inc.. (1/19/21). "Press Release: Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies". Charlottesville, VA. |
2021-01-19 |
T-Knife GmbH. (1/19/21). "Press Release: T-Knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer". San Francisco, CA & Berlin. |
2021-01-19 |
Thermo Fisher Scientific Inc.. (1/15/21). "Press Release: Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep". Waltham, MA & Lyon. |
2021-01-15 |
NewAmsterdam Pharma B.V.. (1/14/21). "Press Release: NewAmsterdam Pharma Completes $196M (€160M) Series A Funding for Comprehensive Phase 3 Development Program". Naarden. |
2021-01-14 |
Affimed N.V.. (1/11/21). "Press Release: Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank". Heidelberg. |
2021-01-11 |
Valo Health LLC. (1/11/21). "Press Release: Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs". Boston, MA. |
2021-01-11 |
Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel. |
2021-01-11 |
Boehringer Ingelheim. (1/11/21). "Press Release: Quantum Computing. Boehringer Ingelheim and Google Partner for Pharma R&D". Ingelheim & Mountain View, CA. |
2021-01-11 |
Addex Therapeutics S.A.. (1/11/21). "Press Release: Addex Successfully Completes $11.5 Million Capital Increase Including Full Exercise of Underwriter’s Option to Purchase Additional Securities". Geneva. |
2021-01-11 |
Immunocore Ltd.. (1/11/21). "Press Release: Immunocore Announces Closing of $75.0 Million Series C Round". Oxfordshire, Conshohocken, PA & Rockville, MD. |
2021-01-11 |
Cevec Pharmaceuticals GmbH. (1/8/21). "Press Release: Cevec Announces New License Agreement for Its AAV Manufacturing Technology Elevecta in Gene Therapy". Cologne. |
2021-01-08 |
Merck KGaA. (1/8/21). "Press Release: Merck Announces Formation of Merck Digital Ethics Advisory Panel". Darmstadt. |
2021-01-08 |
BRAIN AG. (1/7/21). "Press Release: BRAIN Group Expands Its US Products Business with the Successful Acquisition of Biosun Biochemicals Inc.". Zwingenberg. |
2021-01-07 |
Merck KGaA. (1/7/21). "Press Release: Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics". Darmstadt. |
2021-01-07 |
Qiagen N.V.. (1/7/21). "Press Release: Qiagen Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute". Redwood City, CA & Hilden. |
2021-01-07 |
Advicenne S.A.. (1/7/21). "Press Release: Advicenne Announces the Appointment of Peter Meeus as Chief Executive Officer". Paris. |
2021-01-07 |
CureVac N.V.. (1/7/21). "Press Release: CureVac and Bayer Join Forces on COVID-19 Vaccine Candidate CVnCoV". Berlin, Tübingen & Boston; MA. |
2021-01-07 |
Sirion Biotech GmbH. (1/7/21). "Press Release: Sirion Biotech GmbH Licensed Its LentiBoost Transduction Technology to Cellectis". Munich & Cambridge, MA. |
2021-01-07 |
BioGeneration Ventures B.V.. (1/7/21). "Press Release: BioGeneration Ventures BGV IV Fund Closes at €140 Million". Naarden. |
2021-01-07 |
PerkinElmer, Inc.. (1/7/21). "Press Release: PerkinElmer to Acquire Oxford Immunotec Global plc". Waltham, MA & London. |
2021-01-07 |
Ribometrix, Inc.. (1/6/21). "Press Release: Ribometrix Announces Collaboration with Genentech to Discover and Develop RNA-Targeted Small Molecule Therapeutics". Durham, NC. |
2021-01-06 |
Bayer AG. (1/6/21). "Press Release: Leaps by Bayer Leads USD 105 Million Series B Financing in Senti Bio to Develop Next-generation Cell and Gene Therapies Using Advanced Gene Circuit Technology Platform". Leverkusen & South San Francisco, CA. |
2021-01-06 |
Argenx SE. (1/6/21). "Press Release: Argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China". Breda, Shanghai & San Francisco, CA. |
2021-01-06 |
MorphoSys AG. (1/6/21). "Press Release: MorphoSys Appoints Sung Lee as Chief Financial Officer". Planegg. |
2021-01-06 |
Gilead Sciences, Inc.. (1/6/21). "Press Release: Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors". Santa Monica, CA, Oxford & San Jose, CA. |
2021-01-06 |
Moderna, Inc.. (1/6/21). "Press Release: European Commission Authorizes COVID-19 Vaccine Moderna in Europe". Cambridge, MA. |
2021-01-06 |
ViGeneron GmbH. (1/5/21). "Press Release: ViGeneron Signs Global Collaboration Agreement for Ophthalmic Gene Therapy Development". Munich. |
2021-01-05 |
Siemens Healthineers AG. (1/5/21). "Press Release: Siemens Healthineers Proposes Peer Schatz to Annual Shareholders' Meeting as New Supervisory Board Member". Erlangen. |
2021-01-05 |
Volta Medical. (1/5/21). "Press Release: Volta Medical Raises 28 Million USD to Revolutionize Persistent AFib Ablation". Marseille. |
2021-01-05 |
Adrenomed AG. (1/4/21). "Press Release: Adrenomed Supervisory Board Appoints Dr. Wolfgang Baiker as CEO". Hennigsdorf. |
2021-01-04 |
Charles River Laboratories International, Inc.. (1/4/21). "Press Release: Charles River Laboratories Acquires Distributed Bio". Wilmington, MA. |
2021-01-04 |
Faron Pharmaceuticals Oy. (1/4/21). "Press Release: Faron to Present at H.C. Wainwright BioConnect". Turku. |
2021-01-04 |
Arvelle Therapeutics GmbH. (1/4/21). "Press Release: Angelini Pharma Acquires Arvelle Therapeutics to Create a Leading European Innovator in Central Nervous System (CNS) and Mental Health Disorder Treatments". Rome. |
2021-01-04 |
Argenx SE. (1/4/21). "Press Release: Argenx to Present at 39th Annual J.P. Morgan Healthcare Conference". Breda & Ghent. |
2021-01-04 |
Clinigen Group plc. (1/4/21). "Press Release: Clinigen Appoints Sam Herbert as Chief Operating Officer". |
2021-01-04 |
Erytech Pharma. (1/4/21). "Press Release: Erytech to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event". Lyon & Cambridge, MA. |
2021-01-04 |
Moderna, Inc.. (1/4/21). "Press Release: Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel". Cambridge, MA. |
2021-01-04 |
Hologic, Inc.. (1/4/21). "Press Release: Hologic to Acquire Somatex, Leader in Biopsy Site Markers and Localization Technologies, for $64 Million". Marlborough, MA. |
2021-01-04 |
Thermo Fisher Scientific Inc.. (12/31/20). "Press Release: Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex". Waltham, MA. |
2020-12-31 |
Invitae Corporation. (12/29/20). "Press Release: Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference". San Francisco, CA. |
2020-12-29 |
BioNTech SE. (12/29/20). "Press Release: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of Comirnaty". New York, NY & Mainz. |
2020-12-29 |
Exact Sciences Corporation. (12/28/20). "Press Release: Exact Sciences to Participate in J.P. Morgan Healthcare Conference". Madison, WI. |
2020-12-28 |
Aprea Therapeutics, Inc.. (12/28/20). "Press Release: Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS)". Boston, MA. |
2020-12-28 |
Arvinas, Inc.. (12/28/20). "Press Release: Arvinas, Inc. Announces Exercise of Underwriters’ Option to Purchase Additional Shares". New Haven, CT. |
2020-12-28 |
BioNTech SE. (12/23/20). "Press Release: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine". New York, NY & Mainz. |
2020-12-23 |
Cytokinetics, Inc.. (12/23/20). "Press Release: Cytokinetics Regains European Rights to Omecamtiv Mecarbil". South San Francisco, CA. |
2020-12-23 |
Agilent Technologies Inc.. (12/22/20). "Press Release: Agilent Receives Approval for GenetiSure Dx Postnatal Assay in Japan". Santa Clara, CA. |
2020-12-22 |
SomaLogic, Inc.. (12/22/20). "Press Release: SomaLogic Adds $81M to Series A Financing Totaling $214M". Boulder, CO. |
2020-12-22 |
Veracyte, Inc.. (12/22/20). "Press Release: Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer". Whippany, NJ & San Francisco, CA. |
2020-12-22 |
Peptilogics. (12/21/20). "Press Release: Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform". Pittsburgh, PA. |
2020-12-21 |
Servier. (12/21/20). "Press Release: Servier to Acquire Agios Pharmaceuticals’ Oncology Business". Paris & Boston, MA. |
2020-12-21 |
BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz. |
2020-12-21 |
NuCana plc. (12/21/20). "Press Release: NuCana Appoints Andrew Kay as Board Chairman". Edinburgh. |
2020-12-21 |
Evotec SE. (12/21/20). "Press Release: Evotec Partners with Alloy Therapeutics to Expand Its Antibody Discovery Platform". Hamburg. |
2020-12-21 |
Uniqure N.V.. (12/21/20). "Press Release: uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program". Lexington, MA & Amsterdam. |
2020-12-21 |
Atomwise, Inc.. (12/21/20). "Press Release: Atomwise Announces Growing Portfolio of Joint Venture Companies". San Francisco, CA. |
2020-12-21 |
BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine". New York, NY & Mainz. |
2020-12-21 |
Swedish Orphan Biovitrum AB. (12/21/20). "Press Release: Sobi Appoints New Head of North America Ahead of Launch Phase". |
2020-12-21 |
BioNTech SE. (12/19/20). "Press Release: Pfizer and BioNTech Receive Conditional Marketing Authorization by Swissmedic for COVID-19 Vaccine". Zürich & Mainz. |
2020-12-19 |
Bruker Corporation. (12/18/20). "Press Release: Bruker Launches FluoroType SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark". Nehren. |
2020-12-18 |
Atomwise, Inc.. (12/18/20). "Press Release: Atomwise and FutuRx Launch A2i Therapeutics – a New Immuno-Oncology Company Funded by Leading Biopharma VCs and the Israeli Innovation Authority". San Francisco, CA & Ness Ziona. |
2020-12-18 |
908 Devices, Inc.. (12/18/20). "Press Release: 908 Devices Announces Pricing of Initial Public Offering". |
2020-12-18 |
Cadent Therapeutics. (12/17/20). "Press Release: Cadent Therapeutics Enters Agreement to Be Acquired by Novartis". Cambridge, MA. |
2020-12-17 |
Evotec SE. (12/17/20). "Press Release: Evotec Achieves Key Milestones in Its Collaboration with Bristol Myers Squibb on Targeted Protein Degradation". Hamburg. |
2020-12-17 |
Univercells S.A.. (12/17/20). "Press Release: Univercells Holding Raises €70 Million in Series C Financing". Brussels. |
2020-12-17 |
Verily Life Sciences. (12/17/20). "Press Release: Verily Announces $700 Million Investment Round to Accelerate Key Businesses, Including Baseline and Verily Health Platforms". South San Francisco, CA. |
2020-12-17 |
Novartis AG. (12/17/20). "Press Release: Novartis Builds on Commitment to Addressing Need in Neuropsychiatric Disorders with Cadent Therapeutics Acquisition". Basel. |
2020-12-17 |
Seagen Inc.. (12/16/20). "Press Release: Seagen to Present at the J.P. Morgan Healthcare Conference". Bothell, WA. |
2020-12-16 |
BioNTech SE. (12/16/20). "Press Release: BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine". Mainz & Shanghai. |
2020-12-16 |
Agilent Technologies Inc.. (12/16/20). "Press Release: Agilent Announces Webcasts for Investment Community". Santa Clara, CA. |
2020-12-16 |
Syft Technologies Ltd.. (12/16/20). "Press Release: Syft Appoints a VP of Sales - Europe". |
2020-12-16 |
Regeneron Pharmaceuticals, Inc.. (12/16/20). "Press Release: Regeneron Announces Presentation at the 39th Annual J.P. Morgan Healthcare Conference". Tarrytown, NY. |
2020-12-16 |
PerkinElmer, Inc.. (12/16/20). "Press Release: PerkinElmer to Present at J.P. Morgan Healthcare Conference". Waltham, MA. |
2020-12-16 |
Luminex Corporation. (12/16/20). "Press Release: Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference". Austin, TX. |
2020-12-16 |
Neuron23 Inc.. (12/16/20). "Press Release: Neuron23 Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group". South San Francisco, CA. |
2020-12-16 |
Arvinas, Inc.. (12/15/20). "Press Release: Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock". New Haven, CT. |
2020-12-15 |
Eli Lilly and Company. (12/15/20). "Press Release: Lilly Announces Agreement to Acquire Prevail Therapeutics". Indianapolis, IN & New York, NY. |
2020-12-15 |
Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen. |
2020-12-15 |
MagForce AG. (12/15/20). "Press Release: MagForce AG Successfully Completes Private Placement of New Shares". Berlin & Nevada. |
2020-12-15 |
Cellectis S.A.. (12/15/20). "Press Release: Cellectis Announces Withdrawal of Follow-On Offering". New York, NY. |
2020-12-15 |
Arvinas, Inc.. (12/14/20). "Press Release: Arvinas, Inc. Announces Proposed Offering of Common Stock". New Haven, CT. |
2020-12-14 |
InnoSkel S.A.S.. (12/14/20). "Press Release: InnoSkel Launches with €20 Million Series A Financing". Copenhagen. |
2020-12-14 |
Cellectis S.A.. (12/14/20). "Press Release: Cellectis Announces Launch of Follow-On Offering". New York, NY. |
2020-12-14 |
ADC Therapeutics S.A.. (12/14/20). "Press Release: ADC Therapeutics and Overland Pharmaceuticals Announce Formation of Overland ADCT BioPharma to Develop and Commercialize Lonca and other ADCs for Hematologic and Solid Tumor Indications in Greater China |
2020-12-14 |
AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]". |
2020-12-12 |
BioNTech SE. (12/12/20). "Press Release: U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older". New York, NY & Mainz. |
2020-12-12 |
Merck KGaA. (12/11/20). "Press Release: Bavencio (avelumab) Receives Positive CHMP Opinion for First-line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma". Darmstadt. |
2020-12-11 |
BioNTech SE. (12/11/20). "Press Release: Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19". New York, NY & Mainz. |
2020-12-11 |
Nouscom AG. (12/11/20). "Press Release: Nouscom Appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer". Basel. |
2020-12-11 |
Waters Corporation. (12/10/20). "Press Release: Waters Corporation Appoints Pearl S. Huang to Board of Directors". Milford, MA. |
2020-12-10 |
[iito] Business Intelligence. (12/10/20). "The [LSE] Newsletter Is Out! Hand-picked & Manually Edited European and Israeli Life Science Business News". Bremen. |
2020-12-10 |
Tempus Labs, Inc.. (12/10/20). "Press Release: Tempus Announces $200 Million Series G-2 Financing". |
2020-12-10 |
Resolve Biosciences GmbH. (12/10/20). "Press Release: Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis". Monheim. |
2020-12-10 |
Gilead Sciences, Inc.. (12/10/20). "Press Release: Gilead Sciences to Acquire MYR GmbH". Foster City, CA & Bad Homburg. |
2020-12-10 |
PepGen Ltd.. (12/9/20). "Press Release: PepGen Raises $45M Series A". Boston, MA & Oxford. |
2020-12-09 |
CureVac N.V.. (12/9/20). "Press Release: CureVac and Fareva Sign Agreement for Fill & Finish Manufacturing of Curevac’s COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA. |
2020-12-09 |